General form of registration statement for all companies including face-amount certificate companies

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
As Reported
Common Stock
As Reported
Cumulative Effect, Period of Adoption, Adjustment
Convertible Preferred Stock
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Notes Receivable
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Accumulated Other Comprehensive (Loss) Income
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Convertible Preferred Stock
Series E Preferred Stock
Common Stock
Series E Preferred Stock
Additional Paid-In Capital
Series E Preferred Stock
Series E1 Preferred Stock
Common Stock
Series E1 Preferred Stock
Additional Paid-In Capital
Series E1 Preferred Stock
Common Stock
Additional Paid-In Capital
Notes Receivable
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Total
BALANCE at Dec. 31, 2018     $ (276,889)                   $ 276,889                        
BALANCE (in shares) at Dec. 31, 2018     (84,092,669)                   84,092,669                        
Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]                                                  
Issuance of Preferred Stock                           $ 2 $ 134,665 $ 134,667   $ 24,977 $ 24,977            
Issuance of Preferred Stock (in shares)                           16,426,267     3,046,623                
BALANCE at Dec. 31, 2019     $ (436,533)                   $ 436,533                        
BALANCE (in shares) at Dec. 31, 2019     (100,038,109)                   100,038,109                        
BALANCE at Dec. 31, 2018       $ 11 $ 276,878 $ 276,889 $ 13 $ 283,318 $ (249) $ (190,666) $ (96) $ 92,320               $ 2 $ 6,440 $ (249) $ (190,666) $ (96) $ (184,569)
BALANCE (in shares) at Dec. 31, 2018       106,977,440     126,329,695                         19,352,255          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                  
Exercise of Common Stock options                                         708       708
Exercise of Common Stock options (in shares)                                       1,217,255          
Vesting of restricted Common Stock                                       $ 1 7       8
Vesting of restricted Common Stock (in shares)                                       6,904,182          
Issuance of Common Stock for acquisitions                                         3,563       3,563
Issuance of Common Stock for acquisitions (in shares)                                       1,066,373          
Stock-based compensation expense                                         5,215       5,215
Common Stock warrants issued and exercised                                         1,038       1,038
Repayment of notes receivable                                         (249) $ 249      
Repayment of notes receivable (in shares)                                       (76,461)          
Net loss                                             (103,596)   (103,596)
Other comprehensive income                                               171 171
BALANCE at Dec. 31, 2019   $ 159,071   $ 13 436,520 436,533 $ 16 453,242   (294,262) 75 159,071               $ 3 16,722   (294,262) 75 (277,462)
BALANCE (in shares) at Dec. 31, 2019 154,913,934     128,100,821     154,913,934                         26,813,113          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                  
Exercise of Common Stock options                                         132       132
Exercise of Common Stock options (in shares)                                       286,636          
Vesting of restricted Common Stock                                         2       2
Vesting of restricted Common Stock (in shares)                                       1,750,555          
Stock-based compensation expense                                         1,259       1,259
Common Stock warrants issued and exercised                                         124       124
Net loss                                             (21,804)   (21,804)
Other comprehensive income                                               (159) (159)
BALANCE at Mar. 31, 2020                                       $ 16 454,759   (316,066) (84) $ 138,625
BALANCE (in shares) at Mar. 31, 2020                                       156,951,125          
BALANCE at Dec. 31, 2019     $ (436,533)                   $ 436,533                        
BALANCE (in shares) at Dec. 31, 2019     (100,038,109)                   100,038,109                        
BALANCE (in shares) at Dec. 31, 2020                                                 100,038,109
BALANCE at Dec. 31, 2019   159,071   $ 13 $ 436,520 $ 436,533 $ 16 $ 453,242   $ (294,262) $ 75 $ 159,071               $ 3 16,722   (294,262) 75 $ (277,462)
BALANCE (in shares) at Dec. 31, 2019 154,913,934     128,100,821     154,913,934                         26,813,113          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                  
Exercise of Common Stock options                                         325       325
Exercise of Common Stock options (in shares)                                       521,925          
Vesting of restricted Common Stock                                       $ 1 6       7
Vesting of restricted Common Stock (in shares)                                       5,307,357          
Issuance of Common Stock for acquisitions                                         500       500
Issuance of Common Stock for acquisitions (in shares)                                       61,060          
Repurchase of shares for employee tax withholdings                                         (101)       (101)
Repurchase of shares for employee tax withholdings (in shares)                                       (9,308)          
Stock-based compensation expense                                         8,006       8,006
Common Stock warrants issued and exercised                                         1,915       1,915
Common Stock warrants issued and exercised (in shares)                                       692,366          
Reverse recapitalization, net of transaction costs                                       $ 6 380,295       380,301
Reverse recapitalization, net of transaction costs (in shares)                                       63,139,263          
Net loss   (90,432)                                         (34,015)   (34,015)
Other comprehensive income                                               (84) (84)
BALANCE at Dec. 31, 2020   $ 609,253                                   $ 23 844,188   (328,277) (9) 515,925
BALANCE (in shares) at Dec. 31, 2020                                       224,626,597          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                  
Exercise of Common Stock options                                         180       180
Exercise of Common Stock options (in shares)                                       163,228          
Vesting of restricted Common Stock (in shares)                                       56,015          
Issuance of Common Stock for acquisitions                                         159,847       159,847
Issuance of Common Stock for acquisitions (in shares)                                       5,036,142          
Repurchase of shares for employee tax withholdings (in shares)                                       (2,241)          
Stock-based compensation expense                                         2,217       2,217
Net loss                                             (59,108)   (59,108)
Other comprehensive income                                               (12) (12)
BALANCE at Mar. 31, 2021                                       $ 25 $ 1,326,945   $ (387,385) $ (21) $ 939,564
BALANCE (in shares) at Mar. 31, 2021                                       252,436,919